Gapping down
In reaction to disappointing earnings/guidance:
- TEUM -9.1%, SCVL -8.3%, SONC -4.7%, SPLK -0.8%
Other news:
- EDGE -85.8% (announces that the Phase 3 NEWTON 2 study of EG-1962 in aneurysmal subarachnoid hemorrhage is unlikely to achieve its primary efficacy endpoint)
- APRI -35.8% (commenced a public offering of shares of common stock and warrants to purchase shares of common stock)
- NSPR -27.9% (priced offering of ~2.856 mln of its common stock at $1.75/share)
- NVTA -14.6% (priced public offering of 11.11 mln shares of its common stock at a price to the public of $4.50/share)
- MGNX -8.3% (prices 4.5 mln common stock offering at $21.25/share)
- GERN -7% (continued weakness after yesterday's 14% decline)
- ATOS -5.1% (files mixed securities shelf offering)
- GCAP -3.9% (responds to European Securities and Markets Authority statement; does not expect the new regulations to have a material adverse effect on its overall financial results)
- PTCT -2.7% (commences a public offering of 4,000,000 shares of its common stock)
- D -2% (prices offering of 20 mln shares of its common stock at a price per share of $67.85 in connection with the forward sale agreements )
- TSLA -1.7% (Moody's downgrades Tesla's corporate family rating to B3, senior notes to Caa1; Outlook is negative)
- GIS -0.9% (priced 22,727,273 share common stock offering at $44/share)
- INPX -0.8% (files for $200 mln mixed securities shelf offering )
Analyst comments:
- SYF -1.1% (initiated with a Sell at UBS )
![]()